Therapy, for Nycomed Amersham Imaging in the Americas. BrachyHealth.org is dedicated to the physician community involved in prostate brachytherapy and as such is only available to medical professionals through personalized password protection. Dr. John Blasko of the Seattle Prostate Institute leads its world-renowned faculty of urologists, radiation oncologists and medical physicists. This type of brachytherapy is a minimally invasive outpatient procedure, and within days of the procedure, most patients are back to their everyday activities. Currently, one in four prostate cancer patients is treated using seed implants.
Prostate cancer is the most common form of cancer in men.
According to the National Cancer Institute, over 180,000 men will be diagnosed with prostate cancer in 2000, and nearly 32,000 men will die from the disease. An estimated 8 out of 10 men diagnosed with prostate cancer are over 65. Nycomed Amersham plc is a world leader in in-vivo diagnostic imaging and in life sciences.